2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Frontiers in Pharmacology FRONT PHARMACOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.8
134人评分
我要评分
声誉 7.9 影响力 7.2 速度 8.3 | |||||||||||||||||||||
| 期刊ISSN | 1663-9812 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：5.39 | |||||||||||||||||||||
| 2025-2026自引率 | 3.7%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 5.803数据由网友[drocean429]收集提供 | |||||||||||||||||||||
| h-index | 62 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://journal.frontiersin.org/journal/pharmacology
稿件规范性与完整性预检 开始检查>>
| |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | http://www.frontiersin.org/submission/submissioninfo.aspx
稿件规范性与完整性预检 开始检查>>
| |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Peptidylarginine deiminase 4-mediated citrullination in human disease: molecular mechanisms and therapeutic targeting Author: Zou, Ping; Su, Xiao-dan; Tian, Wei; Xie, Xiang-yang; Yang, Ke Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1854078 Comparative pharmacokinetics of periplocin and its four key metabolites in rats after oral administration of periplocin and cardiac glycoside extract from Cortex Periplocae Author: Zhao, Peng; Zuo, Fanjiao; Li, Caixia; Zhao, Yingjing; Li, Yanjin; Wu, Haoran; Zhu, Yameng; He, Jun Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1844009 Berbamine sensitizes hepatocellular carcinoma to chemotherapy by inhibiting autophagy via modulating SIRT1-mediated acetylation Author: Peng, Qin; Xiao, Ling; Huang, Xinhui; Huang, Ziyuan; Zhang, Guangxian; Zhou, Jihong; Tan, Yuhui Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1763828 EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer Author: Wang, Xiaomin; Ding, Yuhang; Mai, Yunxiao; Li, Ruinan; Shao, Xinyu; Chen, Wenlong; Li, Yiming; Liu, Luhaoxiang; Wang, Haoran; Liu, Kangkang; Niu, Yuanjie; Li, Jianmin; Xu, Guoping; Zhao, Yang Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1786648 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Frontiers in Pharmacology的语言要求，还能让Frontiers in Pharmacology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Frontiers in Pharmacology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（4篇） 论文致谢（22篇） 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD3295; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：pharmacology、pharmaceutics、ethnopharmacology、experimental pharmacology、neuropharmacology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||
| 通讯方式 | AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015 | |||||||||||||||||||||
| 出版商 | Frontiers Media S.A. | |||||||||||||||||||||
| 涉及的研究方向 | PHARMACOLOGY & PHARMACY- | |||||||||||||||||||||
| 出版国家或地区 | SWITZERLAND | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 3844点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 99.91% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 69.20% | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1663-9812%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 14 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ USD3295; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Frontiers in Pharmacology顺利发表。
快看看作者怎么说吧：服务好评（4篇） 论文致谢（22篇） 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Peptidylarginine deiminase 4-mediated citrullination in human disease: molecular mechanisms and therapeutic targeting Author: Zou, Ping; Su, Xiao-dan; Tian, Wei; Xie, Xiang-yang; Yang, Ke Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1854078 DOI |
| 2. | Comparative pharmacokinetics of periplocin and its four key metabolites in rats after oral administration of periplocin and cardiac glycoside extract from Cortex Periplocae Author: Zhao, Peng; Zuo, Fanjiao; Li, Caixia; Zhao, Yingjing; Li, Yanjin; Wu, Haoran; Zhu, Yameng; He, Jun Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1844009 DOI |
| 3. | Berbamine sensitizes hepatocellular carcinoma to chemotherapy by inhibiting autophagy via modulating SIRT1-mediated acetylation Author: Peng, Qin; Xiao, Ling; Huang, Xinhui; Huang, Ziyuan; Zhang, Guangxian; Zhou, Jihong; Tan, Yuhui Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1763828 DOI |
| 4. | EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer Author: Wang, Xiaomin; Ding, Yuhang; Mai, Yunxiao; Li, Ruinan; Shao, Xinyu; Chen, Wenlong; Li, Yiming; Liu, Luhaoxiang; Wang, Haoran; Liu, Kangkang; Niu, Yuanjie; Li, Jianmin; Xu, Guoping; Zhao, Yang Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1786648 DOI |
| 5. | Safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate for hyperkalemia management in China: actualize study Author: Shen, Nan; Zeng, Xin; Xie, Hua; Zhang, Lihong; Yang, Jing; Lin, Yongqiang; Liu, Xinyu; Cai, Xudong; Cao, Juan; Zhu, Qiang; Luo, Xun; Wan, Xin; Wu, Henglan; Ye, Jianming; Shan, Chunyan; Wu, Yifan; Cao, Yanping; Lin, Yang; Yu, Xiaoyong; Wang, Huimin; He, Jingdong; Tian, Shaojiang; Wu, Fenglei; Jiang, Xinxin; Li, Lu; Zuo, Li; Wang, Zhaohua; Xing, Changying; Yin, Xun; Zhao, Jianrong; Ma, Cong; Long, Gang; Li, Qing; Hu, Yao; Shi, Yifan; Lin, Hongli Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1744687 DOI |
| 6. | Hypertension associated with systemic therapy for hepatocellular carcinoma and management strategies Author: Li, Yuqing; Wang, Boxuan; Zhang, Dan; Xin, Ying; Wang, Xingyu Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1780200 DOI |
| 7. | Mitigating mitochondrial dysfunction: a novel strategy for Chinese botanical drugs against osteoporosis Author: Li, Shiyu; Liu, Hongyu Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1809770 DOI |
| 8. | Therapeutic advances in traditional Chinese and Tibetan medicine for high-altitude cerebral edema Author: Gao, Yuhui; Luo, Yupan; Chen, Liqiong; Mi, Ergen; He, Ziqi; Shang, Bingbing; Sui, Shaoguang; Zheng, Wanqi Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1796921 DOI |
| 9. | Amelioration of CKD-induced cardiomyocyte hypertrophy by pegmolesatide: involvement of JAK2/STAT3 inhibition and mitochondrial protection Author: Zhang, Xinyu; Li, Sufang; Lin, Tingru; Gan, Liangying; Zheng, Hanze; Zhu, Li; Zuo, Li Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1806374 DOI |
| 10. | Multi-target litholytic strategy toward calcium oxalate stone therapy: a fundamental study Author: Xia, Shasha; Shen, Kaiwen; Yang, Hong; Li, Yaoke; Mu, Weijian; Shen, Jun Journal: FRONTIERS IN PHARMACOLOGY. 2026; Vol. 17, Issue , pp. -. DOI: 10.3389/fphar.2026.1779759 DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共2218条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
